Clinical Trial Update: Saw Palmetto: Symptom Management for Men During Radiation Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating saw palmetto for symptom management in men undergoing radiation therapy for prostate cancer; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Saw Palmetto (Serenoa repens)

Snippet

Sponsor: Michigan State University | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-14